CLEMENS, WENDY L.,ZALEVSKY, JONATHAN,HOCH, UTE,TAGLIAFERRI, MARY
申请号:
CA3081748
公开号:
CA3081748A1
申请日:
2018.11.06
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
This disclosure provides methods for treating a tumor in a subject comprising administering to the subject an anti-PD-1 antibody and a CD-122-biased agonist. In some embodiments, the tumor is derived from a melanoma, a renal cell carcinoma (RCC), a non-small cell lung carcinoma (NSCLC), a urothelial cancer (UC), a breast cancer, or any combination thereof.